Morgan Hubeli
Family · Charlotte, NCNPI 1043885692
Payments from drug & device makers
Across 536 payments — averaging $28.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Aytu Biopharma, Inc.$5K
- AstraZeneca$2K
- GSK$1K
- Regeneron Healthcare Solutions, Inc.$1K
- CSL Behring$714
- Sanofi$553
- plus $4K from 27 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Aytu Biopharma, Inc. | 40 | $4,961 |
| AstraZeneca | 81 | $2,007 |
| GSK | 112 | $1,368 |
| Regeneron Healthcare Solutions, Inc. | 49 | $1,300 |
| CSL Behring | 26 | $714 |
| Sanofi | 16 | $553 |
| ARS Pharmaceuticals Operations, Inc. | 24 | $538 |
| Grifols USA, LLC | 24 | $471 |
| Amgen | 22 | $430 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $380 |
| Novartis | 26 | $349 |
| Kaleo, Inc. | 12 | $251 |
| Octapharma USA, Inc. | 12 | $248 |
| AbbVie | 10 | $230 |
| Incyte Corporation | 6 | $217 |
| Organon | 6 | $189 |
| Optinose US, Inc. | 10 | $183 |
| Pharming Healthcare, Inc. | 4 | $173 |
| Pfizer | 11 | $163 |
| ADMA Biomanufacturing LLC | 6 | $147 |
| Hikma Pharmaceuticals USA | 5 | $89 |
| Ionis Pharmaceuticals, Inc. | 3 | $75 |
| Genentech USA, Inc. | 3 | $70 |
| Biocryst US Sales Co., LLC | 2 | $63 |
| Azurity Pharmaceuticals, Inc. | 2 | $41 |
| Galderma Laboratories, L.p. | 2 | $35 |
| Siemens Medical Solutions USA, Inc. | 1 | $30 |
| Greer Laboratories, Inc. | 1 | $28 |
| Phadia US Inc. | 1 | $26 |
| Tersera Therapeutics LLC | 1 | $22 |
| Invivyd Inc | 1 | $21 |
| GC Biopharma USA, Inc. | 1 | $17 |
| Novo Nordisk | 1 | $12 |
How this compares
$15,400 in reported general payments places this provider in the 95th percentile of 4,522 family providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other family in Charlotte
- Debra ScottCharlotte$129K
- Lasherri LeathersCharlotte$89K
- Catherine ShahCharlotte$72K
- Jason HardinCharlotte$37K
- Laura ListonCharlotte$33K
- Marie KristensenCharlotte$30K
- Hadley DebergCharlotte$16K
- Trisha WootenCharlotte$15K
- Samantha GriffinCharlotte$13K
- Leslie ByrneFayetteville$482K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.